Loading clinical trials...
Loading clinical trials...
A Randomized, Prospective, Multi-Center Feasibility Study of APT001 Plasma/Nitric Oxide Therapy for the Treatment of Diabetic Foot Ulcers
Conditions
Interventions
Standard of Care
Nitric Oxide Therapy 2x week 6 min. plus standard of care
+3 more
Locations
15
United States
Clinical Site
Montgomery, Alabama, United States
Clinical Site
Phoenix, Arizona, United States
Clinical Site
Tucson, Arizona, United States
Clinical Site
Fresno, California, United States
Clinical Site
Los Angeles, California, United States
Clinical Site
San Francisco, California, United States
Start Date
March 20, 2017
Primary Completion Date
May 1, 2018
Completion Date
July 1, 2018
Last Updated
June 7, 2017
NCT07039396
NCT07396376
NCT07116876
NCT07198061
NCT07014176
NCT07109895
Lead Sponsor
Origin Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions